Renaissance Capital logo

SWTX News

US IPO Weekly Recap: Tech and life sciences fare well while SmileDirectClub falls flat in 6-IPO week

MDWL.RC

In the first busy week since the August break, six companies and two SPACs entered the public market. VC-backed health and tech fared well, led by 10x Genomics (TXG) and Cloudflare (NET), while SmileDirectClub (SDC) saw its initial hype evaporate. The largest deal of the week, SmileDirectClub (SDC)...read more

Rare cancer biotech SpringWorks Therapeutics prices IPO at $18 high end

SWTX

SpringWorks Therapeutics, a Phase 3 biotech developing small molecule therapies for rare cancers, raised $162 million by offering 9.0 million shares at $18, the high end of the range of $16 to $18. SpringWorks Therapeutics plans to list on the Nasdaq under the symbol SWTX. J.P. Morgan, Goldman Sachs and Cowen acted as lead managers on the deal....read more

Rare cancer biotech SpringWorks Therapeutics increases proposed IPO deal size

SWTX

SpringWorks Therapeutics, a Phase 3 biotech developing small molecule therapies for rare cancers, raised the proposed deal size for its upcoming IPO on Thursday. The Stamford, CT-based company now plans to raise $153 million by offering 9 million shares at a price range of $16 to $18. The company had previously filed to offer 7.4 million shares at the same range. At the...read more

US IPO Week Ahead: IPO market is all smiles with 6 deals including SmileDirectClub

TXG

After a month-long break, the IPO market is picking up with six deals expected to raise $2.2 billion in the week ahead. Three companies are targeting IPO valuations of $3.5 billion or more. SmileDirectClub (SDC) is the week's largest offering, raising a proposed $1.2 billion at a market cap of nearly $8.0 billion. Over half of proceeds are going to insiders....read more